Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.14M | $0.80 | $32.67 | 4,003.89% | Buy | 3 | N/A | N/A | -893.03% | -105.64% | |||
| FBLG | FIBROBIOLOGICS INC | $18.26M | $0.44 | $13.00 | 2,881.65% | Strong Buy | 2 | N/A | N/A | -5,552.75% | -343.38% | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $2.30M | $1.91 | $45.00 | 2,256.02% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| IMA | IMAGENEBIO INC | $32.17M | $8.00 | $153.00 | 1,812.50% | Buy | 2 | N/A | N/A | -25.12% | -23.08% | |||
| ACXP | ACURX PHARMACEUTICALS INC | $10.32M | $6.51 | $95.50 | 1,366.97% | Buy | 2 | N/A | N/A | -1,395.33% | -808.10% | |||
| MRSN | MERSANA THERAPEUTICS INC | $48.81M | $9.78 | $140.00 | 1,331.49% | Strong Buy | 2 | 12.06% | N/A | N/A | -12.89% | |||
| ATYR | ATYR PHARMA INC | $85.98M | $0.97 | $13.63 | 1,310.46% | Buy | 4 | N/A | N/A | 35.58% | 27.46% | |||
| FGEN | FIBROGEN INC | $43.80M | $10.83 | $146.50 | 1,252.72% | Buy | 2 | N/A | N/A | N/A | -19.10% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $190.98M | $0.63 | $8.33 | 1,216.43% | Strong Buy | 3 | 21.80% | N/A | 230.88% | 46.39% | |||
| PSTV | PLUS THERAPEUTICS INC | $61.54M | $0.62 | $8.00 | 1,190.32% | Strong Buy | 4 | 41.26% | N/A | 359.89% | 105.50% | |||
| NRXP | NRX PHARMACEUTICALS INC | $62.07M | $3.15 | $40.00 | 1,169.84% | Strong Buy | 3 | N/A | N/A | -276.64% | 2,036.49% | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $33.92M | $2.33 | $26.67 | 1,044.51% | Buy | 3 | 405.49% | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $17.24M | $0.63 | $7.00 | 1,005.85% | Strong Buy | 2 | 159.81% | N/A | -122.78% | -18.46% | |||
| GRI | GRI BIO INC | $5.16M | $2.05 | $22.50 | 997.56% | Buy | 2 | N/A | N/A | -26.50% | -15.51% | |||
| UNCY | UNICYCIVE THERAPEUTICS INC | $90.60M | $5.13 | $55.50 | 981.87% | Buy | 2 | N/A | N/A | 796.95% | 436.51% | |||
| TVRD | TVARDI THERAPEUTICS INC | $46.61M | $4.97 | $53.14 | 969.28% | Strong Buy | 7 | 48.92% | N/A | -174.29% | -131.18% | |||
| CING | CINGULATE INC | $20.89M | $3.86 | $39.50 | 923.32% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| LSTA | LISATA THERAPEUTICS INC | $20.21M | $2.35 | $23.50 | 900.00% | Strong Buy | 2 | 240.34% | N/A | -33.23% | -29.08% | |||
| SKYE | SKYE BIOSCIENCE INC | $47.72M | $1.54 | $15.00 | 874.03% | Buy | 3 | N/A | N/A | -140.13% | -117.33% | |||
| INTS | INTENSITY THERAPEUTICS INC | $11.20M | $0.24 | $2.25 | 845.38% | Strong Buy | 2 | N/A | N/A | -517.12% | -254.19% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.41M | $1.07 | $10.00 | 838.97% | Strong Buy | 2 | N/A | N/A | -71.37% | -60.18% | |||
| IMUX | IMMUNIC INC | $73.59M | $0.77 | $7.00 | 811.46% | Strong Buy | 4 | N/A | N/A | N/A | -200.84% | |||
| MDCX | MEDICUS PHARMA LTD | $48.10M | $2.70 | $23.50 | 770.37% | Strong Buy | 2 | N/A | N/A | -82.26% | -22.39% | |||
| NOTE | FISCALNOTE HOLDINGS INC | $62.71M | $4.37 | $37.50 | 758.12% | Strong Buy | 2 | -11.65% | N/A | -33.81% | -11.15% | |||
| JSPR | JASPER THERAPEUTICS INC | $38.52M | $2.37 | $20.14 | 749.92% | Buy | 7 | N/A | N/A | -387.30% | -195.88% | |||
| PASG | PASSAGE BIO INC | $22.71M | $7.14 | $59.25 | 729.48% | Strong Buy | 4 | N/A | N/A | -8.89% | -4.29% | |||
| MBRX | MOLECULIN BIOTECH INC | $14.72M | $0.49 | $4.00 | 723.05% | Buy | 2 | N/A | N/A | N/A | -67.32% | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.28M | $0.43 | $3.50 | 713.95% | Strong Buy | 2 | N/A | N/A | -2,302.04% | 92.61% | |||
| VNRX | VOLITIONRX LTD | $47.34M | $0.44 | $3.50 | 695.45% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| MTVA | METAVIA INC | $23.71M | $0.98 | $7.50 | 665.31% | Strong Buy | 2 | N/A | N/A | -279.09% | -145.51% | |||
| BMEA | BIOMEA FUSION INC | $86.88M | $1.46 | $10.50 | 619.18% | Strong Buy | 6 | N/A | N/A | -311.49% | -117.13% | |||
| MYO | MYOMO INC | $41.96M | $1.11 | $7.83 | 605.68% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.29M | $5.09 | $34.75 | 582.71% | Strong Buy | 2 | 17.65% | N/A | -2.15% | -1.01% | |||
| ACET | ADICET BIO INC | $73.61M | $0.89 | $6.00 | 574.16% | Strong Buy | 2 | N/A | N/A | -47.64% | -40.22% | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $266.26M | $1.20 | $8.00 | 566.67% | Strong Buy | 7 | N/A | N/A | -46.15% | -33.79% | |||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.14M | $2.12 | $14.00 | 560.38% | Buy | 2 | N/A | N/A | -26.10% | -23.31% | |||
| ANVS | ANNOVIS BIO INC | $39.95M | $2.05 | $13.50 | 558.54% | Strong Buy | 2 | N/A | N/A | -160.52% | -137.15% | |||
| CTSO | CYTOSORBENTS CORP | $53.22M | $0.85 | $5.50 | 547.06% | Buy | 2 | 14.28% | N/A | -43.05% | -12.33% | |||
| TIL | INSTIL BIO INC | $130.96M | $19.40 | $125.00 | 544.33% | Buy | 2 | N/A | N/A | -32.66% | -18.62% | |||
| RNXT | RENOVORX INC | $43.24M | $1.18 | $7.50 | 535.59% | Buy | 2 | 222.30% | N/A | 92.98% | 72.52% | |||
| ATOS | ATOSSA THERAPEUTICS INC | $120.39M | $0.93 | $5.88 | 530.36% | Buy | 2 | N/A | N/A | -51.49% | -46.05% | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $13.32M | $10.56 | $65.00 | 515.53% | Buy | 2 | N/A | N/A | N/A | N/A | |||
| HBIO | HARVARD BIOSCIENCE INC | $18.17M | $0.41 | $2.50 | 512.75% | Buy | 2 | -1.63% | N/A | 8.49% | 1.67% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.